STCOSD
AMPH icon

Sageworth Trust Company of South Dakota’s Amphastar Pharmaceuticals AMPH Stock Holding History

Sageworth Trust Company of South Dakota’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-26
Closed -$1K – 263
2022
Q2 		$1K Hold
26
– – ﹤0.01% 429
2022
Q1 		$1K Sell
26
-129
-83% -$3.66K ﹤0.01% 466
2021
Q4 		$4K Buy
+155
New +$3.17K 0.01% 532

Other funds holding AMPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Sageworth Trust Company of South Dakota's AMPH Position: Q3 2022 in Review

Sageworth Trust Company of South Dakota sold out of Amphastar Pharmaceuticals (AMPH) in Q3 2022, closing a stake of 26 shares — an estimated $1K sold.

Sageworth Trust Company of South Dakota first reported a position in AMPH in Q4 2021 and held it in 3 quarters. The position peaked at $4K in Q4 2021. 207 funds tracked by Wall St. Rank hold AMPH as of Q3 2022.

  • Sageworth Trust Company of South Dakota reported no remaining Amphastar Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
  • Sageworth Trust Company of South Dakota sold 26 Amphastar Pharmaceuticals shares in Q3 2022, an estimated $1K.
  • Sageworth Trust Company of South Dakota first reported a position in Amphastar Pharmaceuticals in Q4 2021 and held it in 3 quarters.
  • Sageworth Trust Company of South Dakota's Amphastar Pharmaceuticals position peaked at $4K in Q4 2021.
  • 207 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q3 2022.

Based on Sageworth Trust Company of South Dakota's 13F filing for Q3 2022, filed 2 Nov 2022.